Abpro Holdings, Inc. (ABPO)
0.2040
+0.01
(+4.88%)
USD |
OTCM |
Jun 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.203M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -96.77% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -0.105 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Abpro Holdings, Inc. is a biotechnology company focused on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease. The company was founded in 2004 and is headquartered in Burlington, MA. |
| URL | http://www.abpro.co |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 12, 2008 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Abpro Holdings, Inc. is a biotechnology company focused on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease. The company was founded in 2004 and is headquartered in Burlington, MA. |
| URL | http://www.abpro.co |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 12, 2008 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |